Related Experiment Video
Updated: Jan 27, 2026

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
CircTHBS1 aggravates peritoneal fibrosis by sponging miR-18a-5p and interacting with CTGF
Yanhong Guo1, Silu Zhao1, Xuewen Zhang1
1Department of Nephropathy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Insights
Circular RNAs (circRNAs) are implicated in peritoneal fibrosis, a complication of peritoneal dialysis (PD). This study identifies circTHBS1 as a key player, demonstrating its potential as a therapeutic target for treating peritoneal fibrosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Renal Medicine
Background:
- Peritoneal fibrosis is a significant complication of long-term peritoneal dialysis (PD).
- Circular RNAs (circRNAs) are known to be involved in organ fibrosis.
- The specific role of circRNAs in peritoneal fibrosis progression was previously unclear.
Purpose of the Study:
- To investigate the role of circRNAs in the development of peritoneal fibrosis.
- To elucidate the underlying molecular mechanisms of circRNA involvement in peritoneal fibrosis.
Main Methods:
- CircRNA expression profiling in peritoneal mesothelial cells from PD patients.
- Functional studies of circTHBS1 using gene silencing and overexpression in cell lines.
- In vivo validation in PD mouse models with circTHBS1 knockdown via AAV delivery.
- Analysis of molecular markers and peritoneal function.
Main Results:
- CircTHBS1 was significantly upregulated in PD patients and correlated with fibrosis markers (fibronectin, α-SMA, CTGF).
- Silencing circTHBS1 inhibited epithelial-mesenchymal transition (EMT) in vitro and alleviated peritoneal fibrosis in vivo.
- CircTHBS1 sponges miR-18a-5p, releasing repression on CTGF, and enhances CTGF stability.
Conclusions:
- CircTHBS1 plays a crucial role in promoting peritoneal fibrosis through the miR-18a-5p/CTGF axis.
- CircTHBS1 represents a potential therapeutic target for managing peritoneal fibrosis in PD patients.
Background:
Peritoneal fibrosis is a serious complication of long-term peritoneal dialysis (PD). Previous studies have demonstrated that circular RNAs (circRNAs) play an important role in organ fibrosis. However, whether circRNAs are involved in the progression of peritoneal fibrosis remains largely elusive. This study aimed to investigate the role of circRNAs in peritoneal fibrosis and clarify the underlying mechanisms.
Methods:
CircRNA expression in peritoneal mesothelial cells derived from peritoneal dialysis effluent was profiled using a human circRNA microarray. The function of circTHBS1 was studied through gene silencing and overexpression. qRT-PCR and western blotting were used to detect the expression of relevant molecules. PD mouse models with adeno-associated virus (AAV)-mediated circTHBS1 knockdown were established to investigate the role of circTHBS1 in peritoneal fibrosis using histological staining and peritoneal function analyses.
Results:
CircTHBS1 was significantly upregulated in peritoneal mesothelial cells from long-term PD patients and was positively correlated with the expression of fibronectin, alpha-smooth muscle actin (α-SMA), and connective tissue growth factor (CTGF). Silencing circTHBS1 suppressed epithelial-mesenchymal transition (EMT) in HMrSV5 cells. In vivo, circTHBS1 knockdown significantly alleviated peritoneal thickening and fibrosis, lowered α-SMA expression, and improved peritoneal function in PD mice. Mechanistically, circTHBS1 acted as a sponge for miR-18a-5p, relieving its repression of CTGF, and directly interacted with CTGF, thereby enhancing its stability. CTGF silencing partially attenuated EMT induced by circTHBS1 overexpression and miR-18a-5p inhibition.
Conclusion:
This study suggests that circTHBS1 could be a candidate target for the treatment of peritoneal fibrosis.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Cystic Fibrosis: Management
Sinus disease and chronic...
Peritoneal Dialysis III: Nursing Management
Predator-Prey Interactions

